BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 11269896)

  • 1. Local conjunctival immunotherapy: the effect of dermatophagoides pteronyssinus local conjunctival immunotherapy on conjunctival provocation test in patients with allergic conjunctivitis.
    Núñez JA; Cuesta U
    Allergol Immunopathol (Madr); 2000; 28(6):301-6. PubMed ID: 11269896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind and placebo-controlled study to assess efficacy and safety of a modified allergen extract of Dermatophagoides pteronyssinus in allergic asthma.
    Ameal A; Vega-Chicote JM; Fernández S; Miranda A; Carmona MJ; Rondón MC; Reina E; García-González JJ
    Allergy; 2005 Sep; 60(9):1178-83. PubMed ID: 16076305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Conjunctival provocation test with Dermatophagoides pteronyssinus in the diagnosis of allergic conjunctivitis from house mites].
    Bertel F; Mortemousque B; Sicard H; André C
    J Fr Ophtalmol; 2001 Jun; 24(6):581-9. PubMed ID: 11460053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between the use of adsorbed and aqueous immunotherapy material in Dermatophagoides pteronyssinus sensitive asthmatic children.
    Altintaş D; Akmanlar N; Güneşer S; Burgut R; Yilmaz M; Buğdayci R; Aksungur P
    Allergol Immunopathol (Madr); 1999; 27(6):309-17. PubMed ID: 10611556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of local conjunctival immunotherapy in allergic conjunctivitis.
    Kasetsuwan N; Chatchatee P; Reinprayoon U
    Asian Pac J Allergy Immunol; 2010 Dec; 28(4):237-41. PubMed ID: 21337906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose local nasal immunotherapy in children with perennial allergic rhinitis due to Dermatophagoides.
    Marcucci F; Sensi LG; Caffarelli C; Cavagni G; Bernardini R; Tiri A; Riva G; Novembre E
    Allergy; 2002 Jan; 57(1):23-8. PubMed ID: 11991284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy of specific immunotherapy to cat dander: a double-blind placebo-controlled trial.
    Varney VA; Edwards J; Tabbah K; Brewster H; Mavroleon G; Frew AJ
    Clin Exp Allergy; 1997 Aug; 27(8):860-7. PubMed ID: 9291281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal immunotherapy with Dermatophagoides extract: in vivo and in vitro results of a double-blind placebo-controlled trial.
    Fanales-Belasio E; Ciofalo A; Zambetti G; Ansotegui IJ; Scala E; Paganelli R; Filiaci F
    Rhinology; 1995 Sep; 33(3):126-31. PubMed ID: 8560161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful management of mite-allergic asthma with modified extracts of Dermatophagoides pteronyssinus and Dermatophagoides farinae in a double-blind, placebo-controlled study.
    García-Robaina JC; Sánchez I; de la Torre F; Fernández-Caldas E; Casanovas M
    J Allergy Clin Immunol; 2006 Nov; 118(5):1026-32. PubMed ID: 17088125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy with sublingual birch pollen extract. A short-term double-blind placebo study.
    Horak F; Stübner P; Berger UE; Marks B; Toth J; Jäger S
    J Investig Allergol Clin Immunol; 1998; 8(3):165-71. PubMed ID: 9684190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of sublingual immunotherapy with high-dose mite extracts in asthma: a multi-center, double-blind, randomized, and placebo-controlled study in Taiwan.
    Niu CK; Chen WY; Huang JL; Lue KH; Wang JY
    Respir Med; 2006 Aug; 100(8):1374-83. PubMed ID: 16403616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study.
    Bufe A; Ziegler-Kirbach E; Stoeckmann E; Heidemann P; Gehlhar K; Holland-Letz T; Braun W
    Allergy; 2004 May; 59(5):498-504. PubMed ID: 15080830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of sublingual coseasonal immunotherapy with a monomeric allergoid in Cupressaceae pollen allergy--preliminary data.
    Ariano R; Panzani RC; Mistrello G
    Eur Ann Allergy Clin Immunol; 2005 Mar; 37(3):103-8. PubMed ID: 15918297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy and safety of sublingual immunotherapy with tree pollen extract in children.
    Valovirta E; Jacobsen L; Ljørring C; Koivikko A; Savolainen J
    Allergy; 2006 Oct; 61(10):1177-83. PubMed ID: 16942565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of local nasal immunotherapy in allergic rhinitis: using strips of the allergen dermatophagoides pteronyssinus.
    Tsai JJ; Liao EC; Tsai FH; Hsieh CC; Lee MF
    J Asthma; 2009 Mar; 46(2):165-70. PubMed ID: 19253124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Specific immunotherapy in the treatment of patients with atopic dermatitis--results of double blind placebo controlled study].
    Silny W; Czarnecka-Operacz M
    Pol Merkur Lekarski; 2006 Dec; 21(126):558-65. PubMed ID: 17405298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzyme-potentiated desensitization in children with asthma and mite allergy: a double-blind study.
    Cantani A; Ragno V; Monteleone MA; Lucenti P; Businco L
    J Investig Allergol Clin Immunol; 1996; 6(4):270-6. PubMed ID: 8844506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of short-term immunotherapy using molecular standardized grass and rye allergens compared with symptomatic drug treatment on rhinoconjunctivitis symptoms, skin sensitivity, and specific nasal reactivity.
    Klimek L; Mewes T; Wolf H; Hansen I; Schnitker J; Mann WJ
    Otolaryngol Head Neck Surg; 2005 Oct; 133(4):538-43. PubMed ID: 16213926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allergen-specific immunotherapy with recombinant grass pollen allergens.
    Jutel M; Jaeger L; Suck R; Meyer H; Fiebig H; Cromwell O
    J Allergy Clin Immunol; 2005 Sep; 116(3):608-13. PubMed ID: 16159631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10-production.
    Cosmi L; Santarlasci V; Angeli R; Liotta F; Maggi L; Frosali F; Rossi O; Falagiani P; Riva G; Romagnani S; Annunziato F; Maggi E
    Clin Exp Allergy; 2006 Mar; 36(3):261-72. PubMed ID: 16499636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.